Table 1 Correlation of IL-23 expression with clinicopathological features in 23 OC patients
Clinicopathological Features | Number (n = 23) | IL-231(Mean ± SD) | P value |
|---|---|---|---|
Gender | 0.6927 | ||
Male | 15 | 3.13 ± 2.01 | |
Female | 8 | 3.83 ± 2.02 | |
Age | 0.5850 | ||
≤50 | 4 | 3.16 ± 1.04 | |
>50 | 19 | 3.53 ± 0.25 | |
Tumour size (cm) | 0.4839 | ||
≤5 | 13 | 3.08 ± 0.88 | |
>5 | 10 | 3.73 ± 1.17 | |
Tumour location | 0.7200 | ||
Upper/Middle | 11 | 3.53 ± 0.64 | |
Lower | 12 | 4.11 ± 2.03 | |
TNM stage | 0.0517 | ||
I–II | 18 | 2.86 ± 0.9 | |
III–IV | 5 | 5.11 ± 1.12 | |
Lymphatic metastasis 2 | 0.0105 | ||
No | 6 | 2.6 ± 1.04 | |
Yes | 17 | 6.67 ± 1.16 | |
Distant metastasis 2 | 0.0076 | ||
No | 19 | 3.1 ± 1.02 | |
Yes | 4 | 8.17 ± 1.44 |
